Navigation Links
Details of HER-2/neu Class I Antigen Licensed by TapImmune published in Journal of Immunology: Antigen is a naturally processed epitope for breast cancer vaccines.
Date:1/22/2013

SEATTLE, Jan. 22, 2013 /PRNewswire/ -- TapImmune Inc. (OTCBB: TPIV) is pleased to announce the January publication of a paper titled "Enzymatic Discovery of a HER-2/neu Epitope That Generates Cross-Reactive T-cells", authored by Henle et al, J.Immunol. (2013), 190, 479-488.  This work, performed in the laboratory of Dr Keith Knutson at Mayo Clinic, describes the discovery of a novel HER-2/neu Class I epitope (p373-382) TapImmune has licensed from Mayo Clinic for the development of breast cancer vaccines.  The significance of this work is that this newly discovered antigen is a naturally occurring antigen processed by the proteasome and elicits peptide-specific T-cell responses.  This results in stronger binding to HLA-A2 and more efficient killing of HER-2/neu positive breast cancer cells by activated T-cells compared to the Class I epitope, p369-377 (E75) which was not naturally processed by the proteasome.

"These results provide an explanation of the molecular immunology behind our approach to HER-2/neu immunotherapy," said Mark Reddish Vice President of TapImmune Inc.  "These data describe how the HER-2/neu protein is processed by the proteasome to then be presented for immune recognition and killing.  By revealing the true identity of the immunodominant epitope responsible for class I mediated killing of HER-2/neu positive tumors, it is now possible to generate a true second generation vaccine that incorporates the correct target as it naturally appears on human tumors.  For nearly 20 years the immunology of this key protein has been clouded by contradictory observations, and these data finally provide an understanding of the 'natural target' displayed on human tumors. We expect to combine this immunodominant peptide with our broadly reactive helper peptides that are currently being tested in a phase I trial, to create a tru
'/>"/>

SOURCE TapImmune Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Report Details NCPA Efforts to Drive Greater Medication Adherence
2. ADVENTRX Announces Details Of The Phase 3 Study Of ANX-188
3. CoLucid Pharmaceuticals Details Phase 3 Development Strategy for Lasmiditan to Address Major Unmet Needs in Acute Migraine Therapy
4. Young Innovations, Inc. Provides 2nd Quarter Conference Call Details
5. CryoLife Announces Release Date and Teleconference Call Details for 2012 Second Quarter Financial Results
6. Physician Details Problems with Medicare Approval Process for Power Wheelchairs
7. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
8. Robbins Arroyo LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Hemispherx Biopharma, Inc.
9. MAQUET Cardiovascular Announces U.S. Food and Drug Administration Panel Votes To Reclassify Intra-Aortic Balloon Pumps To A Class II Designation In Certain Indications
10. Barrack, Rodos & Bacine Files Class Action Lawsuit Against St. Jude Medical, Inc.
11. Thomson Reuters Empowers Drug Development and Clinical Professionals to Develop Better, Faster Clinical Trials with Best-in-Class Intelligence Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Sept. 2, 2014   Mast Therapeutics, Inc . (NYSE MKT: ... M. Culley , will present at the Rodman and Renshaw 16 ... at 2:55 p.m. Eastern time in the Holmes II Salon at ... . Interested parties can access a live audio ... www.masttherapeutics.com . An archived presentation will be available on the ...
(Date:9/2/2014)...  BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a ... XIAFLEX ® in the U.S. and XIAPEX ® ... Wegman , will present at the following upcoming investor conferences. ... & Renshaw 16 th Annual Global Investment Conference ... 9, 2014 at 9:10 a.m. EDT , Aegis ...
(Date:9/2/2014)...  MEI Pharma, Inc. (Nasdaq: MEIP ... development of novel therapies for cancer, announced today ... Phase II clinical trial of its lead investigational ... patients with previously untreated intermediate-2 or high-risk myelodysplastic ... a total of 108 patients with a one-to-one ...
Breaking Medicine Technology:Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 2Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 3BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 2MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 3MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 4
... May 24, 2012   Hospira, Inc.  (NYSE: ... injectable drugs and infusion technologies, today released a ... integration of infusion pumps and electronic health records ... which recognizes the important work of healthcare technology ...
... Volcano Corporation (NASDAQ: VOLC ), a leading ... enhance the diagnosis and treatment of coronary and peripheral vascular ... Jefferies 2012 Global Healthcare Conference on Monday, June 4. ... begin at 8 a.m., Eastern Daylight Time (5 a.m., Pacific ...
Cached Medicine Technology:I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process 2I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process 3
(Date:9/2/2014)... How well patients recover from cancer surgery ... conditions and the operations themselves. Family conflicts and ... surgical complications, a Mayo Clinic study has found. ... reduce patients, stress, speed their recoveries and save ... specifically looked at colon cancer patients, and found ...
(Date:9/2/2014)... care for patients who are dying. A study of ... in training feel unprepared and anxious when faced with ... Scientists from the Sahlgrenska Academy have interviewed 222 nursing ... Skvde and the Ersta Skndal University College. The interviews ... their ideas about how to support and meet the ...
(Date:9/2/2014)... 02, 2014 Nanomedicine is essentially ... diagnosing, treating and/or prevention of diseases and infections. ... cardiovascular, neurological, and oncology diseases. , Nanomedicine ... to various nanoparticles, their medical usages, and their ... considerable scope for research in this domain, and ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The performance ... fluctuated over the past five years. Industry revenue is ... 1.0% over the five years through 2014-15, following stabilised ... faced increasing external competition from alternate forms of gambling. ... other online gambling platforms have all become increasingly popular ...
(Date:9/2/2014)... The American Healthcare Documentation Professionals Group ... for its ICD-10 Medical Coding Bridge Program. The purpose ... of confidence to students who are seeking to launch ... faced with the uncertainty brought on by the federal ... October 1st, 2015. , AHDPG’s Free-Tuition Guarantee is simple ...
Breaking Medicine News(10 mins):Health News:Family conflicts, other non-physical worries before cancer surgery raise patients' complication risk 2Health News:Many nurses unprepared to meet dying patients 2Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 2Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 3Health News:Lotteries in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Lotteries in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 3
... ... and its staff members are helping to prepare Certified Professional Coders to meet the upcoming ... ... , a medical billing and practice management company, is pleased to announce that two of ...
... ... respirators universally fit faces, providing a better seal. Our product is available for retail ... our website. , ... Baxter, MN (PRWEB) October 9, 2009 -- Breathe Safely of Baxter Minnesota has created ...
... Sarasota Memorial ... application allows for voice, alarm and text messages to be delivered to the point of ... they have more time to spend caring for patients. , ... Sarasota,Fla (PRWEB) October 9, 2009 --Trey Lauderdale, Vice President ...
... Discussions Also to Feature Top Experts on the Battle Against H1N1 ... reform headed to the floor of the House and Senate, the ... discussions designed to shed light on what the looming changes will ... the Top of the Hill Banquet and Conference Center, at the ...
... time you run nutritionals using the government,s database, you might ... to have received a nutrient boost, virtually overnight. , The ... food entries - including mushrooms, the only fruit or vegetable ... updates made to the United States Department of Agriculture,s (USDA) ...
... League Baseball players have just learned they,re in the running for ... of 10 players, one of whom will go on to receive ... in January. The finalists for the 45th annual Hutch Award are: ... Torii Hunter, Los Angeles Angels of Anaheim Mark Lowe, ...
Cached Medicine News:Health News:Capture Billing Associates Elected to Local Chapter of the American Academy of Professional Coders 2Health News:Breathe Safely, LLC: Making Respirators 270% More Effective 2Health News:Sarasota Memorial Hospital Uses New Technology to Enhance Patient Experience 2Health News:Sarasota Memorial Hospital Uses New Technology to Enhance Patient Experience 3Health News:Tom Daschle, Richard Gephardt and Other Health Care Leaders to Diagnose Health Care Reform Battle in the Final Days of the Debate 2Health News:Tom Daschle, Richard Gephardt and Other Health Care Leaders to Diagnose Health Care Reform Battle in the Final Days of the Debate 3Health News:National Nutrient Database Updated to Include Vitamin D Values 2Health News:National Nutrient Database Updated to Include Vitamin D Values 3Health News:National Nutrient Database Updated to Include Vitamin D Values 4Health News:Ten Finalists Chosen for Hutch Award(R) 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: